Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 93.68M but it saw 78215184 shares traded in last market. With a market cap of 68.83M USD, the company’s current market price of $0.39 came falling about -4.42 while comparing to the previous closing price of $0.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.08 and as low as $0.12. In the recent trading on the day, stock has struck highest price mark of $0.3701 while lowest mark touched by it was $0.434.
Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $0.2861, while its current price level is -97.26% below from 52-week high level whereas it is 226.53% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2102 while that of 200 days or SMA-200 reads an average of $2.2930. A closer look into the stock’s movement over the week reveals that its volatility is standing at 46.41% during that period while stretching the period over a month that decreases to 38.25%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 55.86 which implies that the stock is in neutral territory.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving 15.27% up while it is 102.58% when we observe its performance for the past one month. Year-to-date it is -97.02% down and over the past year, the stock is showing a downside performance of -96.98%.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 186.89M. Company’s return on investment (ROI) stands at -169.47% and return on equity (ROE) at -138.69%. Stock’s beta reads 2.06. Stock has a price to book (P/B) ratio of 0.81 while price to sale or P/S ratio amounts to 6.10. Its return on asset (ROA) is -115.46% on average.
